Biktarvy, formally known as bictegravir, represents a effective single-tablet therapy for treating HIV infection. This drug unites three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the the viral ability to multiply within the body, remarkably reducing the viral quantity. For many indi